The Technical Analyst
Select Language :
Huakang Biomedical [8622.HK]

Exchange: HKSE Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic

Huakang Biomedical Price, Forecast, Insider, Ratings, Fundamentals & Signals

Huakang Biomedical is listed at the  Exchange

5.10% HKD0.103

America/New_York / 17 mai 2024 @ 03:42


Huakang Biomedical: Main Fundamentals PE comparison

Huakang Biomedical PE Comparison

Report updated: 2024-05-17 @ 18:30
Comp Ticker PE
China NT Pharma Group 1011.HK -0.240
HUTCHMED (China) Limited 0013.HK 1.750
Extrawell Pharmaceutical 0858.HK 2.500
Jilin Province Huinan 8049.HK 2.900
Consun Pharmaceutical 1681.HK 4.580
Shenzhen Neptunus 8329.HK 5.230
Golden Throat Holdings 6896.HK 8.120
China Shineway 2877.HK 8.390
Jacobson Pharma 2633.HK 8.500
Guangzhou Baiyunshan 0874.HK 8.510
China Grand 0512.HK 8.650
China Medical System 0867.HK 9.220
Qianhai Health Holdings 0911.HK 10.000
Shandong Xinhua 0719.HK 10.730
Livzon Pharmaceutical 1513.HK 11.760
China Traditional Chinese 0570.HK 12.160
Zhongzhi Pharmaceutical 3737.HK 14.000
Pak Fah Yeow 0239.HK 15.500
Cansino Biologics Inc 6185.HK 15.810
Shanghai Fosun 2196.HK 16.560
Shenzhen Hepalink 9989.HK 17.210
JBM (Healthcare) Limited 2161.HK 20.500
FUDANZHANGJIANG 1349.HK 29.000
Fusen Pharmaceutical 1652.HK 64.500
PuraPharm Corp Ltd 1498.HK 156.960
Tianda Pharmaceuticals 0455.HK 208.900

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.